Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005649 · ClinicalTrials.gov registry record · Phase 2
Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer
A Phase 2 study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00005649: Completed Phase 2 study, sponsored by Hoffmann-La Roche.
NCT00005649 is a Phase 2 study that has completed, run by Hoffmann-La Roche. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005649, a Phase 2 study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of paclitaxel and capecitabine in treating women who have metastatic breast cancer.
Interventions
- DRUG paclitaxel
- DRUG capecitabine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-07 |
| Est. Completion | 2002-07-04 |
| Phase | Phase 2 |
What the finished NCT00005649 record still lists
NCT00005649 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which paclitaxel is the first listed.
NCT00005649 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005649 about?
NCT00005649 is a clinical study titled "Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of paclitaxel and capecitabine in treating women who have metastatic bre...
What is the current status of trial NCT00005649?
This trial is currently completed. It is a Phase 2 study. The study started on 1998-07. Estimated completion is 2002-07-04.
What interventions are being tested in trial NCT00005649?
The interventions under investigation include: paclitaxel (DRUG), capecitabine (DRUG).
Who is sponsoring clinical trial NCT00005649?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia